Magneq Pharma addresses the complex challenges faced by pharmaceutical companies in manufacturing APIs (Active Pharmaceutical Ingredients) and intermediates. We ensure compliance with international regulations like ICH, prioritizing quality, safety, productivity, and environmental sustainability.
Our solutions help companies meet the growing demand for high-quality products while maintaining cost-efficiency and scalability. Operating from our advanced facility in Gujarat, India, we focus on delivering tailored, reliable, and efficient solutions to pharmaceutical businesses worldwide.
Sr. No. | Name of Product | Type | CAS No. | End Use |
---|---|---|---|---|
1 | 2-Chloro-3-Bromopropiophenone | Intermediates | 34911-51-8 | Bupropion HCL / Treat Depression |
2 | Bupropion Base | Intermediates | 34911-55-2 | Bupropion HCL / Treat Depression |
4 | Bis Phenol | Intermediates | 80-05-7 | Bisacody / Treat Constipation |
7 | 7-(4-bromobutoxy)-3,4_dihydroquinolin2(1h)-one | Intermediates | 129722-34-5 | Aripiprazole / Treat Certain Mental/Mood Disorders |
11 | 4-(2-Dethylamino)Ethoxy) Benzophenone | Intermediates | 796-77-0 | Clomiphene Citrate / Treat Infertility in Women |
12 | 1-(4-(2-Dimethylamine)ethoxy) Pheny)-1,2-diphenylethanol | Intermediates | 73404-00-9 | Clomiphene Citrate / Treat Infertility in Women |
13 | Clomiphene Base | Intermediates | 911-45-5 | Clomiphene Citrate / Treat Infertility in Women |
15 | 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile | Intermediates | 112809-25-3 | Letrazol / Treat Certain Types of Breast Cancer |
17 | 1-(4-(2-Dimethylamino)ethoxy) Pheny)-2-PhenylButane-1one | Intermediates | 68047-07-4 | Temoxifen Citrate / Treat Breast Cancer |
18 | 1-(4-(2-Dimethylamino)ethoxy) Pheny)-1,2-diphenyl-Butan-1-Ol | Intermediates | 748-97-0 | Temoxifen Citrate / Treat Breast Cancer |
19 | Temoxifen | Intermediates | 10540-29-1 | Temoxifen Citrate / Treat Breast Cancer |
21 | 2,3-di-o-acetyl-5-deoxy-5-fluorocytidine | Intermediates | 161599-46-8 | Capecitabine / Treat Breast, Colon, or Rectal Cancer |
23 | N-(4-methyl-3-((4-(pyridine-3yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide | Intermediates | 152459-95-5 | Imatinib Meylate / Treat Certain Types of Cancer |
26 | Levitiracetam Crude | Intermediates | 102767-28-2 | Levitiracetam / Treat Seizures (Epilepsy) |
28 | (Methyl N-valeryl-N-[(2-cyanobiphenyl-4-yl)methyl]-l-valinate) | Intermediates | 482577-59-3 | Valsartan / High Blood Pressure |
30 | 4, 7-Dichloroquinoline | Intermediates | 86-98-6 | Hydroxychloroquine / Arthritis, Lupus Erythematosus, and Malaria |
34 | Fluconazole Crude | Intermediates | 86386-73-4 | Fluconazole / Anti-Fungal |
39 | (5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-2-imino-1,3-thiazolidin-4-one) | Intermediates | 105355-26-8 | Pioglitazone Hydrochloride / Improve Blood Sugar Control in Adults with Type 2 Diabetes Mellitus |
40 | ((5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidin-2,4-dione) | Intermediates | 136401-28-9 | Pioglitazone Hydrochloride / Improve Blood Sugar Control in Adults with Type 2 Diabetes Mellitus |
41 | Pioglitazone | Intermediates | 111025-46-8 | Pioglitazone Hydrochloride / Improve Blood Sugar Control in Adults with Type 2 Diabetes Mellitus |
Magneq Pharma
Block No 300, Umiya Industrial Estate, Torrent - Indrad Road,
Village: Indrad, Kadi, Dist: Mehsana 382715, Gujarat
+91 9978656561, +91 9978971306
GST No: 24ABOFM0441L1Z6
© Magneq Pharma. All Rights Reserved.